VR Advisory Services’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

VR Advisory Services’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-160,379	Closed	-$42K	–	22
2020 Q3	$42K	Hold	160,379	–	–	0.04%	19
2020 Q2	$72K	Hold	160,379	–	–	0.12%	19
2020 Q1	$10K	Hold	160,379	–	–	0.02%	17
2019 Q4	$28K	Hold	160,379	–	–	0.04%	16
2019 Q3	$27K	Hold	160,379	–	–	0.05%	15
2019 Q2	$35K	Hold	160,379	–	–	0.04%	18
2019 Q1	$29K	Hold	160,379	–	–	0.03%	22
2018 Q4	$62K	Hold	160,379	–	–	0.05%	15
2018 Q3	$72K	Hold	160,379	–	–	0.05%	17
2018 Q2	$61K	Buy	160,379 +115,772	+260%	+$53K	0.04%	19
2018 Q1	$20K	Buy	+44,607	New	+$17.5K	0.01%	33

Other funds holding NRXPW

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

VR Advisory Services's NRXPW Position: Q4 2020 in Review

VR Advisory Services sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q4 2020, closing a stake of 160,379 shares — an estimated $42K sold.

VR Advisory Services first reported a position in NRXPW in Q1 2018 and held it in 11 quarters. The position peaked at $72K in Q2 2020. 2 funds tracked by Wall St. Rank hold NRXPW as of Q4 2020.

VR Advisory Services reported no remaining NRX Pharmaceuticals Warrant position as of Q4 2020 after selling out during the quarter.
VR Advisory Services sold 160,379 NRX Pharmaceuticals Warrant shares in Q4 2020, an estimated $42K.
VR Advisory Services first reported a position in NRX Pharmaceuticals Warrant in Q1 2018 and held it in 11 quarters.
VR Advisory Services's NRX Pharmaceuticals Warrant position peaked at $72K in Q2 2020.
2 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q4 2020.

Based on VR Advisory Services's 13F filing for Q4 2020, filed 16 Feb 2021.